ATTN LogoMenu
4PTGXTier 4
기사 목록

Protagonist Therapeutics, Inc 4

0001104659-26-105955

View on SEC EDGAR

CEO Dinesh V. Patel gifted 510 shares of Protagonist Therapeutics, Inc. common stock to relatives, leaving him with 522,968 shares owned directly.

On 2026-09-03, Protagonist Therapeutics, Inc. President and CEO Dinesh V. Patel, Ph.D. made a bona fide gift of 510 shares of the company’s common stock to relatives at no consideration, reducing his directly held position to 522,968 shares. As this was a charitable/estate-type transfer rather than an open market transaction, there is no direct price signal or dollar amount involved, and Patel remains a substantial shareholder after the gift.

Filing Facts

CIK
1377121
Ticker
PTGX
Form
4
Source Type
fda
Accession
0001104659-26-105955
Alert Tier
4
Protagonist Therapeutics, Inc 4 | ATTN